Sage Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2018 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Sage Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2018 to 2023.
  • Sage Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -1.53 USD/shares, a 54.6% increase year-over-year.
  • Sage Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -5.57 USD/shares, a 49.3% increase year-over-year.
  • Sage Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -9.05 USD/shares, a 0.78% decline from 2022.
  • Sage Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -8.98 USD/shares, a 15.1% decline from 2021.
  • Sage Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -7.8 USD/shares, a 167% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$9 $0 -0.78% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-14
2022 -$9 -$1 -15.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-14
2021 -$8 -$20 -167% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-14
2020 $11.70 +$25.00 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 -$13 -$5 -65.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$8 Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.